Envista’s (NYSE:NVST) Q4 Sales Beat Estimates
Dental products company Envista Holdings (NYSE:NVST) announced in Q4 CY2024, with sales up 1.1% year on year to $652.9 million. Its non-GAAP profit of $0.24 per share was 9.9% above analysts’ consensus estimates.
J.P. Morgan Remains a Hold on Envista Holdings (NVST)
In a report released yesterday, Rachel Vatnsdal from J.P. Morgan maintained a Hold rating on Envista Holdings (NVST – Research Report), with a
Envista Holdings Corporation (NVST) Q4 2024 Earnings Call Transcript
Envista Holdings Corporation ( NYSE: NVST) Q4 2024 Earnings Conference Call February 5, 2025 5:30 PM ET Jim Gustafson – Vice President-Investor Relations Paul Keel – President and Chief Executive Officer Eric Hammes – Chief Financial Officer
Which Is a Better Investment, Envista Holdings Corporation or QuidelOrtho Corporation Stock?
Learn more about whether Envista Holdings Corporation or QuidelOrtho Corporation is a better investment based on AAII's A+ Investor grades, which compare both companies' key financial metrics.
Envista Holdings Corporation: Envista Reports Fourth Quarter 2024 Results
Envista Holdings Corporation (NYSE: NVST) today announced results for the quarter ended December 31, 2024. "In Q4 2024
Envista: Q4 Earnings Snapshot
The Brea, California-based company said it had net income of 1 cent per share. Earnings, adjusted for amortization costs and restructuring costs, came to 24 cents per share. The results exceeded Wall Street expectations. The average estimate of eight analysts surveyed by Zacks Investment Research was for earnings of 23 cents per share.
Which Is a Better Investment, LeMaitre Vascular, Inc. or Envista Holdings Corporation Stock?
Learn more about whether LeMaitre Vascular, Inc. or Envista Holdings Corporation is a better investment based on AAII's A+ Investor grades, which compare both companies' key financial metrics.
Envista Holdings announces $250 million stock buyback
In a move to enhance shareholder value, Envista Holdings Corp (NYSE:NVST), a company specializing in dental equipment and supplies with a market capitalization of $3.55 billion, announced on Monday a stock repurchase program authorizing the buyback of up to $250 million of its outstanding common stock.
Envista outlines 2025 guidance with 1-3% core growth and $0.95-$1.05 EPS target
Q4 2024 Management View CEO Paul Keel reported Q4 performance in line with expectations, achieving 2% core growth and a 13.9% adjusted EBITDA margin. The implants business, particularly in North ...
Analysts Offer Insights on Healthcare Companies: Cytokinetics (CYTK) and Envista Holdings (NVST)
Companies in the Healthcare sector have received a lot of coverage today as analysts weigh in on Cytokinetics (CYTK – Research Report) and ...
Yahoo Finance15d
Envista Holdings Corporation (NVST)
Envista Holdings Corporation (NYSE: NVST) ("Envista") will report financial results for its fourth quarter 2024 on Wednesday, February 5, 2025. Envista will discuss these results on a conference ...
Seeking Alpha9d
NVST Envista Holdings Corporation
Envista Holdings Corporation (NVST) stock price is 21.37 and Envista Holdings Corporation (NVST) 10-day simple moving average is 20.73. Envista Holdings Corporation (NVST) stock price is 21.37 ...
Earnings call transcript: Enova International Q4 2024 beats EPS forecasts
Enova International Inc (NYSE:ENVA) reported strong fourth-quarter 2024 earnings, surpassing analyst expectations with an adjusted EPS of $2.61, compared to the forecasted $2.27. The company reported ...